Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Gilenya (fingolimod) - Important Safety Information from Novartis as approved by the Irish Medicines Board

11 May 2012

Important Safety Information communication from Novartis regarding cardiovascular events following use of Gilenya.

Important safety information - Gilenya





Date Printed: 19 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971